SCHEMBL4756232

SCHEMBL4756232

NC(C(=O)OC(OC(=O)c1ccccc1)c1ccccc1)C1(CC(=O)O)CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
CYP1A2 P05177 2/20 0.36
LMNA P02545 2/20 0.36
CYP2D6 P10635 1/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
SLC6A2 P23975 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
MAPK1 P28482 2/20 0.33
POLB P06746 2/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1563323 0.87 APOBEC3A (0.39) TSHRLMNAKMT2AMEN1POLB
SCHEMBL25013 0.85 LMNA (0.41) TP53TSHRSLC6A4SLC6A3CYP1A2
SCHEMBL6884986 0.83 TP53 (0.37) TP53TSHRSLC6A4SLC6A3CYP1A2
SCHEMBL4756193 0.81 LMNA (0.36) TP53TSHRSLC6A4SLC6A3CYP1A2
SCHEMBL28755061 0.81 GABBR2 (0.36) CYP1A2LMNAKMT2AMAPK1POLB
SCHEMBL27641457 0.81 ADRB2 (0.43) TSHRSLC6A4SLC6A3CYP1A2LMNA
SCHEMBL5147376 0.78 CYP2D6 (0.36) TP53TSHRSLC6A4SLC6A3CYP1A2
SCHEMBL25331 0.76 GAA (0.39) TP53TSHRSLC6A4SLC6A3CYP1A2
SCHEMBL27910096 0.74 NPSR1 (0.43) SLC6A4SLC6A3CYP1A2LMNASLC6A2
SCHEMBL27622479 0.74 CYP2D6 (0.40) TSHRSLC6A4SLC6A3CYP1A2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101434572-B Prodrugs of GABA analogs, compositions and uses thereof XENOPORT INC 2013-03-13 CN disclosed
CN-101381339-B Prodrugs of gaba analogs, compositions and uses thereof XENOPORT INC 2012-03-07 CN disclosed
CN-1753673-B Prodrugs of GABA analogs, compositions and uses thereof XENOPORT INC 2010-09-29 CN disclosed
CN-101434572-A Prodrugs of GABA analogs, compositions and uses thereof XENOPORT INC (US) 2009-05-20 CN disclosed
CN-101381339-A Prodrugs of gaba analogs, compositions and uses thereof XENOPORT INC (US) 2009-03-11 CN disclosed
WO-2008157408-A2 USE OF PRODRUGS OF GABA ANALOGS, ANTISPASTICITY AGENTS, AND PRODRUGS OF GABA B RECEPTOR AGONISTS FOR TREATING SPASTICITY XENOPORT, INC. (US) 2008-12-24 WO disclosed
EP-1569895-A4 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF XENOPORT INC (US) 2007-07-11 EP disclosed
CN-1753673-A Prodrugs of gaba analogs, compositions and uses thereof XENOPORT INC (US) 2006-03-29 CN disclosed
EP-1569895-A1 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF Xenoport, Inc. (US) 2005-09-07 EP disclosed
WO-2004052844-A1 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF XENOPORT, INC. (US) 2004-06-24 WO disclosed